Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Assisted Reproduction and Genetics
Erschienen in: Journal of Assisted Reproduction and Genetics 6/2006

01.06.2006 | Assisted Reproduction

Subclinical Pregnancy Losses Among Women Undergoing In-Vitro Fertilization With ICSI

verfasst von: Ulun Ulug, Suleyman Tosun, Esra Aksoy Jozwiak, Ali Mesut, Alper Sismanoglu, Mustafa Bahceci

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 6/2006

Einloggen, um Zugang zu erhalten

Abstract

Background: The purpose of this study is to asses the frequency of subclinical pregnancy loss (SPL) among women undergoing controlled ovarian hyperstimulation (COH) and in-vitro fertilization with ICSI.
Methods: The study was retrospectively conducted in a private IVF center. SPL was defined by a temporary rise in serum βhCG, along with the absence of signs of intra- and extra-uterine pregnancy by transvaginal ultrasonography. Overall 5273 COH and ICSI cycles with embryo transfer (ET) were segregated according to serum E2 levels percentiles (-24th, 25th, 74th, and 75th), women age and the type of spermatozoa for assisted fertilization (ejaculated and surgically retrieved). Those groups were assessed for SPL rates.
Results: Among the 3125 (59.25) conception cycles, 305 (9.7%) were diagnosed as SPL. There was no difference in SPL rate among E2 percentile groups. Women older than 35 years of age had significantly higher rate of SPL compared to younger women. There was also no difference in SPL rate among pregnancies in whom surgically retrieved spermatozoa used or ejaculated spermatozoa used for assisted fertilization.
Conclusion: Our results demonstrated that SPL rate was not influenced by the levels of E2 during COH or the origin of spermatozoa used for assisted fertilization. However, maternal age was found to be detrimental for SPL.
Literatur
1.
Steinkampf MP, Guzick DS, Hammond KR, Blackwell RE: Identification of early pregnancy landmarks by transvaginal sonography: Analysis by logistic regression. Fertil Steril 1997;68:168–170PubMedCrossRef
2.
Coulam CB, Chapman C, Rinehart JS: What is a preclinical pregnancy loss? J Assist Reprod Genet 1998;15:184–187PubMedCrossRef
3.
Simon C, Cano F, Valbuena D, Remohi J, Pellicer A: Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Hum Reprod 1995;10:2432–2437PubMed
4.
Yang JH, Chen HF, Lien YR, Chen SU, Ho HN, Yang YS: Elevated E2:oocyte ratio in women undergoing IVF and tubal ET. Correlation with a decrease in the implantation rate. J Reprod Med 2001;46:434–438PubMed
5.
Ng EH, Lau EY, Yeung WS, Ho PC: Oocyte and embryo quality in patients with excessive ovarian response during in vitro fertilization treatment. J Assist Reprod Genet 2003;20:186–191PubMedCrossRef
6.
Sharara FI, Lim J, McClamrock HD: Endometrial pattern on the day of oocyte retrieval is more predictive of implantation success than the pattern or thickness on the day of hCG administration. J Assist Reprod Genet 1999;16:523–528PubMedCrossRef
7.
Ng EH, Yeung WS, Yee Lan E, So WW, Ho PC: High serum oestradiol concentrations in fresh IVF cycles do not impair implantation and pregnancy rates in subsequent frozen-thawed embryo transfercycles. Hum Reprod 2000;15:250–255CrossRef
8.
Chen CH, Zhang X, Barnes R, Confino E, Milad M, Puscheck E, Kazer RR: Relationship between peak serum estradiol levels and treatment outcome in in vitro fertilization cycles after embryo transfer on day 3 or day 5. Fertil Steril 2003;80:75–79PubMedCrossRef
9.
Mahutte NG, Duleba AJ, Taylor HS, Arici A, Jones E, Sakkas A: Elevated estradiol levels are associated with increased miscarriage rates in women undergoing IVF/ICSI. Fertil Steril 2002;78(Suppl 1):S253 (abstract)CrossRef
10.
Bonduelle M, Van Assche E, Joris H, Keymolen K, Devroey P, Van Steirteghem A, Liebaers I: Prenatal testing in ICSI pregnancies: Incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters. Hum Reprod 2002;17:2600–2614PubMedCrossRef
11.
Coulam CB, Opsahl MS, Sherins RJ, Thorsell LP, Dorfmann A, Krysa L, Fugger E, Schulman JD: Comparisons of pregnancy loss patterns after intracytoplasmic sperm injection and other assisted reproductive technologies. Fertil Steril 1996;65:1157–1162PubMed
12.
Govaerts I, Devreker F, Koenig I, Place I, Van den Bergh M, Englert Y: Comparison of pregnancy outcome after intracytoplasmic sperm injection and in vitro fertilization. Hum Reprod 1998;13:1514–1518PubMedCrossRef
13.
Orvieto R, Ben-Rafael Z, Ashkenazi J, Yoeli R, Messing B, Perri T, Shalev Y, Bar-Hava I: Outcome of pregnancies derived from assisted reproductive technologies: IVF versus ICSI. J Assist Reprod Genet 2000;17:385–387PubMedCrossRef
14.
Wennerholm UB, Bergh C, Hamberger L, Westlander G, Wikland M, Wood M: Obstetric outcome of pregnancies following ICSI, classified according to sperm origin and quality. Hum Reprod 200;15:1189–1194CrossRef
15.
Schieve LA, Tatham L, Peterson HB, Toner J, Jeng G: Spontaneous abortion among pregnancies conceived using assisted reproductive technology in the United States. Obstet Gynecol 2003;101:959–967PubMedCrossRef
16.
Gibbons WE, Toner JP, Hamacher P, Kolm P: Experience with a novel vaginal progesterone preparation in a donor oocyte program. Fertil Steril 1998;69:96–101PubMedCrossRef
17.
Miles RA, Paulson RJ, Lobo RA, Press MF, Dahmoush L, Sauer MV: Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: A comparative study. Fertil Steril 1994;62:485–490PubMed
18.
Morris NM, Udry JR: Daily immunologic pregnancy testing of initially nonpregnant women. Am J Obstet Gynecol 1967, 98:1148–1150PubMed
19.
Walker EM, Lewis M, Cooper W, Marnie M, Howie PW: Occult biochemical pregnancy: Fact or fiction? Br J Obstet Gynaecol 1988;95:659–663PubMed
20.
Chard T: Frequency of implantation and early pregnancy loss in natural cycles. Baillieres Clin Obstet Gynaecol 1991;5:179–189PubMedCrossRef
21.
Fishel SB, Edwards RG, Evans CJ: Human chorionic gonadotropin secreted by preimplantation embryos cultured in vitro. Science 1984;24, 223:816–818CrossRef
22.
Lopata A, Hay DL: The potential of early human embryos to form blastocysts, hatch from their zona and secrete HCG in culture. Hum Reprod 1989;4(Suppl):87–94PubMed
23.
Fridstorm M, Garoff L, Sjoblom P, Hilensjo T: Human chorionic gonadotropin in early pregnancy after assisted reproduction. Acta Obstet Gynecol Scand 1995;74:534–538CrossRef
24.
Ulug U, Jozwiak EA, Mesut A, Berksoy MM, Bahceci M: Survival rates during the first trimester of multiple gestations achieved by ICSI: A report of 1448 consecutive multiples. Hum Reprod 2004;19:360–364PubMedCrossRef
25.
26.
Papageorgiou T, Guibert J, Goffinet F, Patrat C, Fulla Y, Janssens Y, Zorn JR: Percentile curves of serum estradiol levels during controlled ovarian stimulation in 905 cycles stimulated with recombinant FSH show that high estradiol is not detrimental to IVF outcome. Hum Reprod 2002;17:2846–2850PubMedCrossRef
27.
Kosmas IP, Kolibianakis EM, Devroey P: Association of estradiol levels on the day of hCG administration and pregnancy achievement in IVF: A systematic review. Hum Reprod 2004;19:2446–2453PubMedCrossRef
28.
Plachot M: The human oocyte. Genetic aspect. Ann Genet 1997;40:115–120PubMed
29.
Gelety TJ, Buyalos RP: The influence of supraphysiologic estradiol levels on human nidation. J Assist Reprod Genet 1995;12:406–412PubMedCrossRef
30.
Akagbosu F, Marcus S, Abusheikha N, Avery S, Brinsden P: Does ovarian hyperstimulation syndrome affect the quality of oocytes? Hum Reprod 1998;13:2583–2584PubMedCrossRef
31.
Basir GS, O WS, Ng EH, Ho PC: Morphometric analysis of peri-implantation endometrium in patients having excessively high oestradiol concentrations after ovarian stimulation. Hum Reprod 2001;16:435–440PubMedCrossRef
32.
Poikkeus P, Hiilesmaa V, Tiitinen A: Serum HCG 12 days after embryo transfer in predicting pregnancy outcome. Hum Reprod 2002;17:1901–1905PubMedCrossRef
33.
Legro RS, Paulson RJ, Lobo RA, Sauer MV: Association of early beta-human chorionic gonadotrophin values with pregnancy wastage and multiple implantation in a donor oocyte programme. Hum Reprod 1995;10:3293– 3296PubMed
34.
Sugantha SE, Webster S, Sundar E, Lenton EA: Predictive value of plasma human chorionic gonadotrophin following assisted conception treatment. Hum Reprod 2000;15:469–473PubMedCrossRef
35.
Levy T, Goldman JA, Dicker D, Ashkenazi J, Feldberg D: Very early pregnancy wastage in in vitro fertilization and embryo transfer (IVF-ET). J In Vitro Fertil Embryo Transf 1991;8:250–253CrossRef
36.
Lenton EA, Woodward AJ: The endocrinology of conception cycles and implantation in women. J Reprod Fertil Suppl 1988;36:1–15PubMed
37.
Liu HC, Rosenwaks Z: Early pregnancy wastage in IVF patients. J In Vitro Fertil Embryo Transf 1991;8:65–72CrossRef
38.
Munne S, Alikani M, Tomkin G, Grifo J, Cohen J: Embryo morphology, developmental rates, and maternal age are correlated withchromosome abnormalities. Fertil Steril 1995;64:382–391PubMed
39.
Palermo GD, Colombero LT, Hariprashad JJ, Schlegel PN, Rosenwaks Z: Cromosome analysis of epididymal and testicular sperm in azoospermic patients undergoing ICSI. Hum Reprod 2002;17:570–575PubMedCrossRef
40.
Bahceci M, Ulug U: Does underlying infertility aetiology impact on first trimester miscarriage rate following ICSI? A preliminary report from 1244 singleton gestations. Hum Reprod 2005;20:717–721PubMedCrossRef
41.
Damario MA, Goudas VT, Session DR, Hammitt DG, Dumesic DA: Crinone 8% vaginal progesterone gel results in lower embryonic implantation efficiency after in vitro fertilization – embryo transfer. Fertil Steril 1999;72:830–836PubMedCrossRef
42.
Propst AM, Hill JA, Ginsburg ES, Hurwitz S, Politch J, Yanushpolsky EH: A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization – embryo transfer cycles. Fertil Steril 2001;76:1144–1149PubMedCrossRef
43.
Pritts EA, Atwood AK: Luteal phase support in infertility treatment: A meta-analysis of the randomized trials. Hum Reprod 2002;17:2287–2299PubMedCrossRef
Metadaten
Titel
Subclinical Pregnancy Losses Among Women Undergoing In-Vitro Fertilization With ICSI
verfasst von
Ulun Ulug
Suleyman Tosun
Esra Aksoy Jozwiak
Ali Mesut
Alper Sismanoglu
Mustafa Bahceci
Publikationsdatum
01.06.2006
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 6/2006
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-006-9038-0

Weitere Artikel der Ausgabe 6/2006

Journal of Assisted Reproduction and Genetics 6/2006 Zur Ausgabe

Original Paper

Outcome of frozen-thawed blastocysts derived from gonadotropin releasing hormone agonist or antagonist cycles

Original Paper

The efficacy and safety of managing ectopic pregnancies with transvaginal ultrasound-guided local injections of absolute ethanol

Assisted Reproduction

Is a lower dose of cetrorelix acetate effective for prevention of LH surge during controlled ovarian hyperstimulation?

Assisted Reproduction

Influence of the Preimplantation Embryo Development (Ped) Gene on Embryonic Platelet-Activating Factor (PAF) Levels

Assisted Reproduction

Prenatal Diagnosis of Meckel–Gruber Syndrome in a Pregnancy Obtained With ICSI

Assisted Reproduction

Human papilloma virus DNA exposure and embryo survival is stage-specific

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 Medikamente in Schwangerschaft und Stillzeit Nachrichten

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise